• Profile
Close

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease

Histopathology Feb 28, 2018

Kendall TJ, et al. - The proposition explored herein was that elastin content was predictive of clinical outcome and thereby could be quantified to increase the beneficial information yield from a liver biopsy in the case of an advanced fibrotic liver disease. It was revealed that elastin was robustly quantified in an operator- and laboratory-independent manner, with a very strong correlation of elastin staining measured by two methods of image classification. During this research, a simple and reproducible method for elastin quantification was elucidated in liver biopsies. This approach yielded potentially valuable prognostic information to inform the clinical management.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay